Isolation and Characterization of Human Vascular Endothelial Cells with Application to Studies of the Subendothelial Matrix

1987 ◽  
pp. 1-27 ◽  
Author(s):  
RANDALL H. KRAMER ◽  
MARVIN A. KARASEK ◽  
KLAUS G. BENSCH
2013 ◽  
Vol 49 (3) ◽  
pp. 189-195 ◽  
Author(s):  
Masanori Nasu ◽  
Taka Nakahara ◽  
Noriko Tominaga ◽  
Yuichi Tamaki ◽  
Yoshiaki Ide ◽  
...  

Author(s):  
Kenji Taniguchi ◽  
Naoki Harada ◽  
Iwao Ohizumi ◽  
Michiko Kinoshita ◽  
Yasuo Tsutsumi ◽  
...  

1992 ◽  
Vol 67 (04) ◽  
pp. 468-472 ◽  
Author(s):  
Joan Dawes ◽  
Duncan S Pepper

SummaryHeparin and other anticoagulant glycosaminoglycans were radiolabelled with 125I and their catabolism by human vascular endothelial cells in culture was studied. Heparin, heparan sulphate and pentosan polysulphate were associated with the cellular fraction and incorporated into the subendothelial matrix, but dermatan sulphate was not found in either fraction. High molecular weight, fully desulphated carbohydrate chains were major catabolic products of all those glycosaminoglycans which were taken up by the cells. Pentosan polysulphate was not degraded further, but the catabolism of heparan sulphate, and to a lesser extent that of heparin, also yielded small oligosaccharides. Thus the first step in catabolism of exogenous glycosaminoglycans by human vascular endothelial cells appears to be complete desul-phation, which destroys their biological activity, followed by depolymerisation of the carbohydrate chain. This alternative to the sequential action of lysosomal exoenzymes is dependent upon binding to the cell; thus dermatan sulphate, which is not associated with the cellular fraction, is not catabolised.


2020 ◽  
Vol 21 (10) ◽  
pp. 3632
Author(s):  
Tetsuya Okuda

Glycosphingolipids containing very-long-chain fatty acids (VLCFAs) regulate several immune responses, such as cytokine production, immune signaling, and antibody induction. We previously reported that stimulation with an inflammatory mediator, TNF-α, promotes the expression of glycosphingolipids in vascular endothelial cells. The major component is globotetraosylceramide containing VLCFAs (Gb4Cer-VLCFAs), but its role in inflammatory responses has not been fully investigated. In this study, the antibody-inducing properties of Gb4Cer-VLCFAs were analyzed using serum and hybridoma cells generated from Gb4Cer-VLCFA-immunized mice. The reactivity of serum antibodies against Gb4Cer indicated that immunization with Gb4Cer-VLCFAs immediately induced the production of anti-Gb4Cer antibodies. Over 81% of hybridomas generated from the splenocytes of an immunized mouse produced anti-Gb4Cer antibodies, a subset of which recognized an epitope shared by Gb4Cer and its precursor globotriaosylceramide (Gb3Cer). Further biochemical analyses of established monoclonal antibodies revealed that these antibodies included IgM and IgG3, which specifically react with Gb4Cer and Gb3Cer. These results indicate that immunization with Gb4Cer-VLCFAs can efficiently induce the production of anti-Gb4Cer and -Gb3Cer antibodies by B cells.


1990 ◽  
Vol 167 (1) ◽  
pp. 294-300 ◽  
Author(s):  
Terry D. Hexum ◽  
Carl Hoeger ◽  
Jean E. Rivier ◽  
Andrew Baird ◽  
Marvin R. Brown

Sign in / Sign up

Export Citation Format

Share Document